Promising Biomarkers for Early Diagnosis: Advances in Understanding the Pathogenesis of Diabetic Peripheral Neuropathy
Diabetes, Metabolic Syndrome and Obesity · 2026-02 · Volume 19 · 1-23
DOI: 10.2147/dmso.s568751 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diabetes, Metabolic Syndrome and Obesity, 2026-02. Verfasst von Qingqin Lyu und 4 weiteren Autor:innen. Beteiligte Einrichtung: National Health Data Institute, Shenzhen, 518033, People's Republic of China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Diabetic peripheral neuropathy (DPN) is one of the most common chronic complications of diabetes mellitus. The most common type is distal symmetric polyneuropathy, and lesions frequently lead to disabling neuropathic pain and even amputation, increasing the risk of death. At present, the pathogenesis of DPN has not been clarified, and its insidious onset and lack of obvious symptoms in most patients in the early stages often lead to delayed diagnosis, which is unfavourable for prevention and treatment. This article provides an overview of the existing research progress on early diagnostic markers of DPN, especially oxidative stress-related markers, neural tissue damage markers, inflammation-related markers, neurovascular damage markers, and gene-related markers, in the hope that it can provide a reference for early diagnosis and treatment of DPN, and slow down the occurrence and development of DPN.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Health Data Institute, Shenzhen, 518033, People's Republic of China.
- The Fourth Clinical Medical College, Guangzhou University of Chinese Medicine, Shenzhen, 518033, People's Republic of China.
- Department of Endocrinology, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, 518033, People's Republic of China.
ORCID-Profile: Xianqi Zeng, Maosheng Lee
Zitieren
APA
Lyu, Q., Tan, Y., Zeng, X., Peng, S., & Lee, M. (2026). Promising Biomarkers for Early Diagnosis: Advances in Understanding the Pathogenesis of Diabetic Peripheral Neuropathy. Diabetes, Metabolic Syndrome and Obesity, Volume 19, 1-23. https://doi.org/10.2147/dmso.s568751
Vancouver
Lyu Q, Tan Y, Zeng X, Peng S, Lee M. Promising Biomarkers for Early Diagnosis: Advances in Understanding the Pathogenesis of Diabetic Peripheral Neuropathy. Diabetes, Metabolic Syndrome and Obesity. 2026;Volume 19:1-23. doi:10.2147/dmso.s568751
BibTeX
@article{Lyu2026,
author = {Lyu, Qingqin and Tan, Yanyan and Zeng, Xianqi and Peng, Siping and Lee, Maosheng},
title = {Promising Biomarkers for Early Diagnosis: Advances in Understanding the Pathogenesis of Diabetic Peripheral Neuropathy},
journal = {Diabetes, Metabolic Syndrome and Obesity},
year = {2026},
volume = {Volume 19},
pages = {1--23},
doi = {10.2147/dmso.s568751}
}
EUVIMED